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4Terminology
•  COPD – Chronic Obstructive Pulmonary Disease (for example: 
emphysema or chronic bronchitis). Typically, a chronic, 
irreversible airway obstruction resulting in breathing difficulties.
•  End of Life (EoL) – Refers to the last 12 months of a person’s life 
(as far as that time period can be known).
•  Family – Refers to family members, close friends and carers – 
recognising that people with substance use difficulties often have 
fractured family relationships and may consider close friends to 
be more of a family to them than their blood relatives. 
•  Palliative Care (PC) – A holistic approach to maximising quality of 
life for people with terminal or complex illness where symptoms 
need to be controlled. Focusing on the prevention and alleviation 
of suffering, this includes not only pain management but also 
psychosocial and spiritual support for both the individual and 
their family, friends and carers.
•  Problematic substance use (PSU) – A subjective definition 
which differentiates problematic alcohol or other drug use 
from recreational consumption or non-problematic use. Other 
terms such as misuse or abuse are often catch all phrases for 
any illicit substance use rather than focussing as we do here on 
problematic substance use. Problems may relate to physical or 
mental health issues, criminal justice involvement, financial and 
employment difficulties, family life, social support or housing, but 
may also include feelings of guilt or shame; secrecy about use; 
concerned family or friends; reliance on alcohol/drugs to relax or 
feel better; memory loss; or regularly using more than intended. 
•  Substance Use (SU) – refers to the use of alcohol or illicit 
drugs (including those controlled under the Misuse of Drugs 
Act 1971). For our research, we are focusing not only on drugs 
controlled under the Misuse of Drugs Act 1971, but also use of 
new psychoactive substances (NPS) and misuse of prescription 
medicines. Use of tobacco is excluded.
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6“…it seems completely 
alien to us why 
somebody would 
drink themselves to 
death but when you 
understand the context 
of somebody’s life 
and the things they’ve 
been through, it makes 
sense...” 
Substance use professional
This policy document is designed to create 
greater understanding for a group of people who 
are as entitled as any citizen to sympathetic and 
expert care, particularly when they are dying. It 
is designed to help all those people of good will 
in the NHS, social and other health care services, 
who want to answer the call of every patient who 
is in need.
People with problematic substance use often 
present with multiple and complex health 
and social care needs. At one extreme, this is 
exemplified by the homeless person with a long 
history of substance use, estranged from their 
family and suspicious of service involvement 
and intervention. At the other is the professional 
whose problematic substance use is better hidden 
among the protections that their increased 
wealth and social status affords, yet whose 
substance use is having an impact on their health 
and social relationships. In this mix, are strained 
relationships with family, including children, 
friends and carers; a group of people who very 
often need support in their own right. Where this 
set of circumstances intersects with life-limiting 
or terminal illness, the challenges of providing 
care to all who need it are magnified.
Growing ‘invisible’ need and 
inequality of care
There are currently no clear estimates of the 
number of people with problematic substance 
use in need of palliative or end of life care 
(Webb et al., 2018). The data are not collected 
to allow for accurate estimates of incidence or 
prevalence. However, reports from professionals 
within hospice services suggest they are seeing 
increasing numbers of people with problematic 
substance use at, or near, the end of their lives 
(Galvani et al. 2018). While such reports suggest 
an increase in women and younger adults 
presenting with palliative/chronic healthcare and 
substance use problems, it is an older cohort of 
people who are more likely to present with both 
sets of needs.
The Case for Change
The reported  
increase in people 
presenting to palliative  
and end of life care services  
with problematic substance  
use looks set to continue,  
bringing a range of  
challenges.
In the UK, it is older generations of substance 
users who have the highest rates of substance-
related hospital admissions, particularly alcohol 
(NHS, 2018). Trends suggest this will continue as 
a result of our ageing demographic and our ability 
to live longer with a range of health problems. 
Thus, the reported increase in people presenting 
to palliative and end of life care services with 
problematic substance use looks set to continue 
bringing with it a range of challenges and service 
demands that need to be addressed.
7Inequalities in palliative and end of life care have 
been recognised among many groups of people, 
including people with conditions other than 
cancer, people with dementia, people from black 
and minority ethnic groups, people with mental ill 
health, learning disabilities or homeless people, 
to name a few (Care Quality Commission, 2016). 
People with problematic substance use are not 
among them. Research suggests this is a group 
of people who often receive poor quality health 
and social care, as their substance use diverts 
professionals’ attention from their underlying 
health and social care needs (Galvani et al, 2018; 
Templeton et al. 2018; Witham et al. 2018). 
This group of people 
often receive poor quality 
health and social care as 
their substance use diverts 
professionals’ attention from 
their underlying health and 
social care needs.
This work would focus on the broad range of 
complex needs including, for example, COPD, 
Hepatitis B and C, HIV, liver disease, social 
isolation, mental health difficulties, homelessness, 
suicide prevention, and cardiovascular diseases. 
Ideally this work would take place within a public 
health policy framework – with Public Health 
England (PHE), Department of Health and Social 
Care, and NHS England, working together to jointly 
address these cross-cutting challenges. Only by 
taking such an epidemiological perspective can we 
fully gauge the true impact of these complex care 
needs upon the health and social care system. 
This document aims to support that conversation, 
support policy development and facilitate the 
translation of such policy moves into service 
delivery plans. 
There is a need to 
start an integrated 
policy conversation to 
address effectively the  
multi-faceted problems  
faced by people with 
problematic substance use 
and terminal health 
problems.
The need for integrated policy 
development
This is a newly exposed area of concern that is yet 
to be reflected in policy. There is a need to start 
an integrated policy conversation at a national, 
strategic level, to develop a blended approach 
with commitment and joint planning from all 
relevant providers. Such policy should drive the 
integration of work between NHS Trusts, local 
authorities and third sector organisations to 
address effectively the multi-faceted problems 
that people with problematic substance use and 
terminal health problems face. 
Key policy standards
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1 Develop public health policy which assertively counters stigma  and stereotyping relating to substance use and serious ill health.
2 Develop national, local and organisational policy that supports  co-existing substance use and end of life care needs in practice.
3 Create policy that promotes accessible care environments and offers the required support to people with substance problems at the end of life.
4 Ensure policy directives bring people together to work jointly across substance use, palliative/end of life and primary care.
5 Ensure policies informing education and training equip health and care professionals to work with people who use substances at end of life.
6 Ensure policy identifies and responds to the needs of people who are important to the person with substance problems at the end of life.
9About the policy standards
These policy standards are grounded in the 
practice experience of a range of professionals in 
leadership and policy roles across health, social 
care, and specialist palliative and end of life care, 
and substance use services in Liverpool, England. 
They have been underpinned by an exploratory 
research programme that sought a range of 
perspectives on palliative and end of life care for 
people with problematic substance use (Galvani, 
2018). Thus, the resulting standards reflect a 
combination of the empirical research findings, 
the existing international evidence base, and the 
frontline and strategic experiences of this range  
of professionals. 
There has been much discussion about whether 
or not the standards presented have an order 
or priority. They are clearly interlinked and 
overlapping. What appears to be increasingly 
clear, is that the inequality in access to good 
palliative and end of life care for this group of 
people is often a result of stigma and stereotyping. 
Without addressing this barrier, practice is unlikely 
to improve, whatever the policy asks.
The standards have been written for a wide 
audience of policy makers. These include 
national policy makers such as public health, 
national charity, social care and National Health 
Service leads through to local policy makers 
including clinical commissioning group leads 
or directors of local authorities. Last, but not 
least, they target policy makers within service 
provider organisations, such as medical directors, 
chief executives, and team leaders. It is often 
at organisational level that the innovative and 
creative work is done to address the challenges  
of daily practice.
We recognise the difficulty of identifying palliative 
or end of life care needs among a group of 
people who die of a number of substance-
related conditions other than cancers, or whose 
substance use co-exists alongside their serious 
health needs. Timescales for planning can be very 
short and occasionally non-existent, but for others 
an improved policy framework will support people 
with problematic substance use to have better 
quality palliative and end of life care.
The standards are the first of their kind and 
are intended to begin conversations about 
policy development and subsequent practice 
improvement. They have been kept broad enough 
for interpretation and application at a local 
level. Some will be more obviously applicable to 
substance specialists or palliative and end of life 
care specialists, while others will apply across the 
spectrum of health and social care policy. 
The goal of presenting a combined policy 
standards document is to enable joint 
consideration of the implications of policy 
development in this area. In other words, while 
one standard may focus more clearly on palliative 
and end of life care specialists, for example, 
there will almost certainly be implications of that 
standard for joint working and support from other 
specialist areas of practice. Policy developed with  
a mutual understanding or a range of perspectives 
is more likely to succeed than policy developed  
in silos.
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Who do we mean by people 
with experience?
There are a range of contexts within which people 
use, and have problems with, substances. Some 
will not be visible or come to the attention of 
services until late in their substance using careers, 
for example, due to failing health. Others will 
face multiple challenges and needs, be familiar 
with, and excluded from, statutory services and 
be reliant on voluntary services. People with 
problematic substance use can be completely 
disenfranchised from their families. In such cases, 
professionals (including volunteers) can play a 
crucial support role in their lives. The figure below 
provides just four examples of people at different 
points in their substance use and the challenges 
they, and the people in their lives, may face when 
they are in need palliative or end of life care. 
Person with history of  
problematic use –  
no current use
Person with problematic use  
within a family setting and  
not in touch with services
May have serious concerns 
about stigma/discrimination 
from services and seek to keep  
history private.
Support network may also have 
history of substance use and be 
wary of negative practitioner 
judgements.
May decline painkillers 
despite serious pain due to 
fears of relapse, dependence, 
or prescription change and 
withdrawal.
May be minimising health 
difficulties (or substance use may 
be masking symptoms), and so 
they, and their family, do not 
perceive how ill they are.
 Strained family relationships. 
Support network may not know 
full extent of their substance  
use and be struggling to know 
how to respond.
May underestimate the extent 
of the harm resulting from their 
problematic substance use.
11
May be struggling to maintain 
engagement in treatment as 
their health deteriorates.
Person receiving support  
to address their  
problematic use
Person who is homeless  
and using substances 
problematically
Need specialist medical SU 
input to plan care and pain 
management addressing 
concerns including over- 
and under- prescribing pain 
medication.
Possibility of strained family 
relationships (‘heard it before’) 
and a peer network of  
substance users.
Staff likely to need emotional 
support and regular supervision 
to support the complex social 
and medical needs.
Housing status/provision will be 
a key concern and health and 
social care needs may have to be 
addressed on an outreach basis.
 Need specialist SU input to 
plan care and pain management 
due to a range of basic and 
complex health and social  
care needs.
Lack of (or problematic)  
social support.
Communication between 
agencies needs to be clear and 
efficient to avoid the person 
slipping through the net.
Evidence repeatedly illustrates the stereotyping 
and stigmatising attitudes faced by people with 
substance problems from a range of health and 
social care professionals as well as the general 
public. Research exploring end of life care and 
substance use found many distressing examples 
where such stereotypical assumptions had led to 
harm (Galvani et al., 2018). Key Standard 1 sets 
out the need to counter such attitudes and locate 
education within a public health framework.
12
1 Develop policy which assertively counters 
stigma and stereotyping relating to substance 
use and serious ill health.
1. Develop a national 
public health campaign 
which counters the 
stigma and stereotyping 
around problematic 
substance use including 
print and visual media, 
and social media. 
2. Ensure EoL and PC 
policy includes people 
with PSU as among 
those suffering health 
inequalities.
3. Develop a national 
public health media 
campaign about death 
and dying and how to 
have the conversation 
about planning for 
death. 
1. Develop a local public 
health campaign which 
counters the stigma and 
stereotyping around 
problematic substance 
use including print and 
visual media, and social 
media. 
2. Ensure local 
initiatives addressing 
health inequalities in 
EoL and PC service 
provision include people 
with PSU.
3. Commission specific 
services for people 
near the end of their 
lives, drawing on good 
examples such as the 
Death Cafe. Ensure that 
PSU are part of the 
target group.
1. Raise practitioner 
awareness to end 
stereotyping & 
stigmatisation of people 
with PSU, and promote 
an understanding of 
the complex needs and 
histories of this group  
of people.
2. Increase the 
knowledge of palliative 
and end of life care 
within substance use, 
housing and social 
care agencies with 
specific focus on early 
intervention and 
advanced care planning.
3. Ensure explicit 
organisational 
commitment to equality 
of service provision for 
people with PSU and 
end of life care needs.
National Local Organisational
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There is a need to move away from models of 
individual responsibility and blame, to more 
community and environmental models that 
acknowledge the histories and vulnerabilities of 
this group of people – particularly at the end of 
life. The stigma associated with drug use means 
that the treatment that people with substance 
problems seek is often viewed suspiciously by 
health practitioners who question whether 
the individual might be ‘drug seeking’ through 
prescribed medication. This impairs clinical 
judgement and has been known to lead to people 
being refused any treatment despite being 
seriously ill (Galvani et al., 2018).
As a society, we need to develop a lot more 
understanding about people with substance 
problems, and about palliative and end of life 
care, not least to encourage people to identify 
themselves to health and social care professionals 
more readily – so that the true scale of need 
becomes evident. It is only by removing the stigma 
associated with problematic substance use that 
we can ensure that people who need help feel 
able to seek it, confident in the knowledge that 
appropriate services and informed professionals 
exist to respond to their needs. 
Within many health and social care organisations, 
there may be a substantial amount of professional 
concern about whether and how to ask people 
using services about their drug and alcohol use 
and about asking about complex health conditions 
and plans for end of life. Without prior experience 
or training on how to hold these conversations, 
many practitioners feel embarrassed or worried 
about asking. Yet failure to ask about substance 
use or palliative and end of life care needs 
merely avoids the problem, resulting in missed 
opportunities to engage people in appropriate 
services.
Case studies
An individual accessing alcohol treatment 
has been in hospital twice with severe 
stomach pain. Despite not drinking 
alcohol recently, the hospital has given 
him Librium both times – seeking to 
provide him with a detox rather than 
finding out about his recent abstinence 
from alcohol and addressing his actual 
health concerns (Galvani et al. 2018, p. 
39). Good practice would see the health 
professionals finding out about the 
current realities of an individual’s life, and 
not relying on historic medical records 
and making decisions based on that 
information. 
A medical director of a substance use 
service was asked to visit a hospice where 
a woman with cancer was a patient. The 
woman smoked heroin and was insistent 
on continuing to do so. The nurses did 
not know how to manage this and were 
not receptive to the idea of her leaving 
the hospice to smoke – yet she could not 
use illegal drugs on their premises. The 
medical director was able to alleviate 
the nurses’ concerns and encouraged 
them to allow the woman to stay in the 
hospice whilst leaving the premises for 
short periods to smoke. This case shows 
the need to challenge risk management 
approaches to drug users and accept 
their need to continue using drugs as 
one more aspect of holistic, patient-
centred care. Good policies should 
promote palliative and end of life care 
teams (and other health and social care 
practitioners) seeking early guidance from 
substance use specialists to ensure that 
their approaches are not stigmatising or 
discriminatory. 
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There is currently no policy that recognises co-
existing substance use and palliative and end 
of life care needs. Key Standard 2 commits to 
improve policy development at national, local 
and organisational levels. In particular, it strongly 
supports integrated policy development and 
commissioning between health and social care 
agencies where limited resources could be 
combined to good effect. These might include 
partnership working between, for example, public 
and community-based health services, adults’ and 
children’s social care, prisons, probation services, 
and housing to name a few.
2 Develop national, local and organisational policy that supports co-existing substance use and 
palliative and end of life care needs in practice
1. Revisit plans for a national 
dataset for palliative and end of 
life care ensuring alcohol/ drug 
use is included.
2. Ensure national substance 
use policy reflects that not 
everyone will recover – 
reintroduce a harm reduction 
component.
3. Develop/disseminate 
model care pathways that 
demonstrate early access 
to primary, acute and end 
of life care for people with 
problematic substance use.
1. Ensure local policy and 
commissioning of PC/EoLC 
includes monitoring of co-existing 
substance use needs. 
2. Ensure local substance use policy, 
including needs assessments, 
consider those who are older and/
or at, or near, their end of life.
3. Develop and monitor 
pathways between services that 
provide early access to specialist 
services (including for example: 
an ARBI pathway), particularly 
those that include psychosocial 
interventions and harm reduction 
approaches. 
1. Set up organisational 
level monitoring and 
recording systems of 
alcohol/drug use among 
people receiving PC/EoLC.
2. Develop policy guidance 
for working with substance 
use and end of life care, 
building on existing relevant 
policies where appropriate.
3. Enable staff to facilitate 
early identification and 
access to primary, acute and 
end of life care for PSUs.
4. Introduce data requirement 
to record potential need for 
palliative or end of life care,  
e.g. discuss feasibility of adding 
to NDTMS.
5. Revisit plans for a national 
liver disease strategy and 
expand to include deaths 
directly attributable to 
problematic substance use.
4. Require SU services to 
record and monitor systematic 
identification of complex health, 
PC and end of life care, to 
establish local need.
5. Develop local good practice 
in data collection on substance-
related deaths in the interim 
while awaiting national 
leadership.
4. Routine identification and 
recording of multiple and 
complex needs including PSU 
and EoL care needs.
5. Collaborate on interim 
recording measures across 
the region. Respond to 
the implications for the 
new strategy and datasets 
at organisational level, in 
particular joint working 
requirements. 
National Local Organisational
15
In addition, a number of policy recommendations 
spanned national, local and organisational levels. 
These include:
•  Appointing a champion or sponsor / 
organisational lead for taking this work forward.
• Developing appropriate service standards, 
quality outcomes and measures of success 
and monitor/evaluate them – including cost 
effectiveness.
• Committing resources to meet need. For 
example, accommodation for people with 
problematic substance use and palliative and 
end of life care needs who are not able/do 
not want to stay in a hospice setting but need 
intensive medical support.
The following Figures 2a – 2c break down 
the activity into three proposed stages of 
development: ‘Foundation’, ‘Enhanced’ and 
‘Developed’, based on a combination of perceived 
need, ease of development, and resource 
demands. 
Foundation level: this level is perceived to 
comprise policy-related activities that are more 
easily achievable in the immediate to short term. 
They may, for example, build on existing review 
or monitoring mechanisms or require smaller 
changes to existing policy or practice.
Enhanced level: the Enhanced level of policy 
demonstrates an extra degree of development and 
attention to supporting people with co-existing 
problematic substance use and palliative or end 
of life care needs. This may include initiatives at 
each level and new collaborations and integrated 
working, for example.
Developed level: this level may require more 
time than the others in terms of resources or 
planning. It would be the level to aim for if seeking 
to achieve the highest level of excellence in policy 
standards. It is also the level that includes more 
creative and aspirational policy responses.
Planning and review tool
The three levels comprise activities that 
are dynamic and can be adapted to suit 
individual organisations’ needs. They could 
be used as a tool for organisational planning 
and review with additional activities being 
added as needed. Each level and activity 
could then be broken down further into 
more detailed work plans.
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Figure 2a. Stages of national policy development
Key standard 2 contains a number of areas for national policy attention.
Improving recording and monitoring data
1.	 	The	National	Drug	Treatment	Monitoring	System	only	monitors	people	in	substance	use	
treatment.	There	are	a	large	number	of	people	who	sit	outside	of	treatment	who	need	
to	be	captured	and	recorded	through	health	and	social	care	monitoring	or	wider	general	
population	survey	data.	
2.	 Adult	Social	Care	need	support	to	access	local	NDTMS	data	to	inform	their	plans	for	
integrated	working.	
3.	 There	also	needs	to	be	consideration	given	to	how	to	access	information	about	people	
with	these	co-existing	needs	within	care	homes	and	other	residential	placements	both	
to	determine	prevalence	and	incidence	but	also	to	equip	staff	to	respond	appropriately	
through	additional	training	and	support.
Foundation
1. Review national 
substance use strategies to 
strengthen harm reduction 
components.
2. Introduce a data 
requirement to record 
chronic health problems 
and PC/EoL care needs, e.g. 
discuss feasibility of adding 
to NDTMS.
3. Revisit plans for a national 
dataset on PC/EoL care 
needs.
Enhanced
4. Develop and disseminate 
model care pathways for SU 
and EoL care.
5. Develop and monitor 
service standards, quality 
outcomes and measures 
of success, including cost 
effectiveness.
6. Appoint a champion/
sponsor to take this work 
forward.
Developed
7. Develop a UK clinical 
evidence base on palliative/
end of life treatment for 
people with substance 
problems.
8. Commit resources to meet 
need, e.g. accommodation 
for people with intensive 
care needs (including 
substance use), who are not 
able to stay in a hospice.
9. Revisit plans for a National 
Liver Strategy expanding 
it to deaths attributable to 
substance use.
Figure 2b. Stages of local policy development
Local policy development is often led by national policy priorities or there is an expectation that national 
policy will be interpreted and applied at a local level. However, there are opportunities for initiatives to 
be led by local policy makers in addition to national diktats. As with national level policy, the following 
three stages are suggested as a combination of perceived need, ease of development, and resource 
demands.
Foundation
1. Ensure local substance 
use policy, including needs 
assessments, consider those 
who are older and/or at end 
of life. 
2. Require services to 
monitor access to, and 
systematic identification of 
PSU within, primary, acute, 
palliative and end of life care.
Enhanced
4. More integrated 
commissioning, including on 
a care pathway basis.
5. Develop appropriate 
service standards, quality 
outcomes and measures 
of success including cost 
effectiveness.
6. Initiate joint community 
of practice/policy work for 
substance use and end of 
life care.
Developed
7. Develop and monitor  
local evidence base/
database on EoL/PC for 
people with PSU.
8. Commit resources to 
meet need. 
9. Develop local policy to 
implement the new strategy 
in collaboration with other 
government departments/
other relevant services.
Figure 2c. Stages of organisational policy development
Much good practice in terms of policy development begins at an organisational level where good care or 
clinical practice develops in response to need. Subsequently, it requires a policy framework to provide 
consistent application across the organisation. These stages reflect some of the good practice already in 
place in some organisations and also messages from organisations about what needs to be developed.
Enhanced
4. Develop local care 
pathways to support 
work with people with 
problematic substance use 
and end of life care.
5. Develop appropriate 
service standards, quality 
outcomes and measures 
of success including cost 
effectiveness. 
Developed
7. Routine identification and 
recording of multiple and 
complex needs.
8. Commit to supporting/
joint staffing any new service 
or resources for people with 
problematic substance use 
at the end of their lives.
9. Respond to the 
implications for the new 
strategy at organisational 
level – in particular joint 
working requirements.
Foundation
1. Develop policy guidance 
for working with substance 
use and end of life care, 
building on existing relevant 
policies where appropriate.
2. Enable staff to facilitate 
early identification and 
access to primary, acute, 
palliative and end of life care 
for PSUs.
3. Appoint an organisational 
lead to take this work forward.
17
18
18
Case study: what good looks like
•  The Liverpool Joint Working Group arose from work of the Drug-Related Death panel examining 
sudden deaths among people engaged in substance use treatment. Analysis of these deaths identified 
a substantial number of people who had died in their 40s and 50s, having had multiple chronic health 
problems (commonly including COPD), and very complex medication regimens. Many of them had 
not been accessing any specialist healthcare services. An initial meeting between substance use and 
palliative care services revealed the latter were equally worried about their staff struggling to manage 
people, both clinically and psychologically, with problematic substance use and finding elements of 
the behaviour of some people very challenging. The Liverpool Joint Working Group was set up as 
a result, inviting local commissioners, healthcare providers, hostels and mental health services to 
collaborate. The group have identified a lack of clear care pathways and a lack of awareness about 
each other’s services which impairs service delivery. Over the past two years, they have run joint 
training days between palliative care and substance use service staff to promote awareness of each 
other’s services and foster better working relationships. They also meet on a regular basis to discuss 
joint areas of concern, thereby building relationships, providing mutual advice, support, knowledge 
and insight into each other’s practice. 
•  A specialist older people’s alcohol service based in Birmingham built strong relationships with a 
Palliative Care Consultant from their local statutory team as well as a Pharmacist in the geographical 
area. This enabled them to seek advice and support when people in the service presented with 
potential life limiting conditions (PC consultant) or ask about medication combinations (Pharmacist) 
taken by people they were supporting.
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Appropriate and accessible care environments are required to meet the needs of people with problematic 
substance use at the end of life. These may take a range of forms and sit within, and outside of, existing 
service provision. Key Standard 3 emphasises the need to ensure that such care is available.
3 Create policy that promotes accessible care 
environments and offers the required support 
to people with problematic substance use at  
the end of life
1. Develop policy 
guidance outlining 
different models of care 
to support this group 
of people at the end of 
their lives.
2. Pilot and evaluate 
specialist residential EoL 
care for people with SU 
problems.
3. Develop and promote 
policy on routine 
enquiry into substance 
among palliative 
care patients/chronic 
healthcare needs among 
SU service users.
1. Review 
commissioned care 
provision locally to 
determine what could 
be adapted to meet the 
needs of this group of 
people.
2. Consider whether 
some modest additional 
resources would enable 
existing commissioned 
service provision to 
provide specific care to 
this group of people.
3. Ongoing review of 
prevalence of need 
for palliative/EoL care 
among people with 
PSU, and vice versa, to 
inform commissioning 
decisions.
1. Consider additional 
organisational needs to 
provide more accessible 
care to people with PSU 
at end of life.
2. Discuss the options 
for additional resources 
with funders to provide 
services for people with 
PSU at end of life.
3. Commit to routine 
enquiry into (1) 
substance among 
palliative care patients, 
and (2) chronic and 
life-limiting health 
conditions among 
substance use service 
users.
4. Consider operational 
models including 
assertive outreach, 
advocacy for referrals 
and case management 
approaches to ensure 
someone retains 
oversight of each 
person’s needs wherever 
they are in the system.
4. Provide dissemination 
and recognition of 
‘beacon’ services where 
there is good policy and 
practice in this area.
4. Recognise and 
promote local 
organisations 
demonstrating good 
policy and practice 
in end of life care 
responses to people 
with PSU.
National Local Organisational
Examples of accessible resources needed
Current	gaps	in	resources	include:	public-facing	navigation	help	for	accessing	services;	 
a	bespoke	service,	e.g.	residential	place	for	people	with	EoL	care	needs	who	continue	to	
use	substances,	who	need	intense	care,	and	are	unable/unwilling	to	live	within	a	hospice	
environment;	complex	care	beds;	complex	care	packages;	‘pathway’	specialists	to	advocate	for	
this	group	of	people	(e.g.	with	acute,	primary	and	social	care);	single	provider	subcontracting	
service	provision;	and	governance	structures	where	accountability	is	across	all	agencies.
Case studies: what good looks like
•  A strong working partnership was developed between the alcohol service and a hostel for homeless 
people, one of whose residents was approaching the end of her life and wanted to die there. Working 
closely together, the hostel, a specialist GP, the local alcohol nurse, homeless nurse, palliative care 
team and district nurses all collaborated to ensure that the woman died where she wanted. Good 
policy development would ensure this type of approach on a routine basis for everybody needing 
palliative and end of life care.
•  A woman who was sleeping rough was discovered to have had tests at the local hospital but had 
self-discharged without knowing what the results were. No attempt had been made by the hospital 
to contact either her last registered GP or local homelessness services. She had ovarian cancer. 
Fortunately, she was treated by a GP practice that specialises in supporting people who are homeless 
and who were very proactive in assessing and dealing with her healthcare needs. A policy to make 
explicit the need for liaison between hospital services and specialist community services would help 
to ensure that vulnerable adults are supported irrespective of their self-discharge from inpatient 
services.
•  Systematic screening for hepatitis C was introduced into a specialist substance use service – with 
automatic referral into Hep C treatment services for anyone with a positive diagnosis. Whilst 36% of 
patients were identified and then referred, treatment completion was only 12% (which in itself was 
a successful increase from the previous rate of 5%). However, this highlighted that many people find 
it hard to move from getting a referral into accessing the service itself – often because of a lack of 
social support and fear of stigma. In this case, hepatitis C nurses now provide hepatitis treatment in 
the substance use service – straight after appointments for substitute prescriptions (where needed), 
in order to maximise attendance. Without this move to enhance the accessibility of treatment, many 
people with hepatitis C would remain untreated.
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A clear message from the diverse range of professionals involved in supporting people with problematic 
substance use at the end of their lives was the lack of consistent joint working and the need for it when 
working with this group of people. Key Standard 4 highlights this aspect of policy development and 
implications for improved practice responses.
4 Ensure policy directives bring people together 
to work jointly across substance use, palliative, 
end of life and primary care 
1. Ensure national 
strategies integrate 
planning on palliative 
care, chronic health 
conditions and  
substance use.
2. Define key national 
palliative care pathways 
that address chronic 
life-shortening health 
conditions at a much 
earlier stage, including  
GP and liver specialists.
3. Highlight the need 
for and good practice 
in information sharing 
protocols (ISPs) between 
hospitals and community 
services.
1. Establish a multi-
agency leadership forum 
to develop policy and 
practice on substance  
use and palliative/end of 
life care.
2. Map key service 
providers to identify 
(potential) screening and 
healthcare pathways and 
profile what joined up 
local policy/practice could 
look like.
3. Develop or refine 
information sharing 
protocols between 
hospital and community 
services.
1. Build communication 
channels across chronic 
health departments within 
NHS Foundation Trusts.
2. Establish assessment 
and referral processes with 
palliative and substance use 
services across the health 
and social care sectors.
3. Develop a joint 
community of practice/
policy work for SU & EoL 
care  through which to 
action information sharing 
protocols.
4. Appoint lead or 
organisation champion 
to support other staff in 
accessing resources and 
other partner agencies.
5. Develop peer advocacy 
and peer support roles to 
support individuals and 
families, as well as offering 
extra help and support to 
professionals.
6. Develop organisational 
standards addressing staff 
care to prevent burnout, 
e.g. inter-disciplinary 
supervision, peer support.
4. Dedicate funding for 
information provision at 
an operational level and 
specific posts to drive this 
work forward.
4. Create a single point 
of access for localised 
clinical/operational 
guidance around palliative 
care and substance use 
for frontline staff. 
National Local Organisational
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Need for joint working policies to support professionals and people with lived experience
General	practitioners,	acute	health	care	providers	and,	to	a	lesser	extent,	social	care	providers	
are	most	criticised	for	their	lack	of	understanding,	poor	or	negative	attitudes	to	people	with	
problematic	substance	use	and	for	not	providing	good	enough	care	at	the	end	of	life	(Galvani,	
2018).	Evidence	shows	that	where	effort	had	been	made	to	develop	positive	local	relationships	
between	Pharmacists,	GPs	and	substance	use	services,	there	were	notable	exceptions.	Hospice	
and	substance	use	staff	were	viewed	as	providing	good,	often	holistic,	support	but	there	was	
little	joint	working	(Galvani	et	al.,	2018).	
Policies	need	to	recognise	the	emotional	labour	inherent	in	working	with	these	complex	issues	
and	allow	for	effective	supervision	and	support	for	staff.	This	will	help	to	maintain	the	mental	
health	of	health	and	social	care	practitioners	and	minimise	staff	burnout	and/or	turnover.	Staff	
are	likely	on	occasion	to	become	very	upset	by	what	happens.	This	work	is	very	different	to	
‘traditional	palliative	care’	which	is	generally	calm,	controlled	and	organised.
Case studies: what good looks like
•  Robert has respiratory disease and severe breathlessness. As he smokes, the oxygen therapy he needs 
at home poses risks. Robert’s doctor is mindful that he is already on an opiate substitute prescription 
and wants to share oversight of Robert’s opioid treatment with his substance use service. Having 
maintained Robert well on methadone for a while, both prescribers are now considering trying to 
switch him to slow-release morphine. 
• Gerry has a long history of homelessness, hostel living and substance use. Following his admittance 
to a hospice, his health improved enough for him to socialise outside the hospice. However, his 
behaviour became more challenging for the hospice when he was intoxicated and all attempts to talk 
to him about it failed. As staff needed to consider the tranquillity and well-being of other hospice 
residents and their families, they had no choice but to evict him. This was an incredibly difficult 
process for hospice staff as well as resulting in a return to homelessness for Gerry. By being in the 
hospice, he had lost his place in the hostel. However, a positive solution was found through the staff 
from the hostel, the hospice and substance use services working together to find a way of keeping 
him safe by providing care in the community and in the hostel when he was allocated a bed. Such 
joint working enabled staff to feel less distressed and more comfortable with the necessary course of 
action. In turn, this can avoid burnout or the avoidance of working with people with complex needs. 
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A key requirement for good partnership working and interagency relationships is the need for some mutual 
understanding of different perspectives, priorities and constraints. Key Standard 5 focusses on the need for 
education and training to underpin improved support for people with problematic substance use at the end 
of life as well as support for staff working with people with complex social and health care needs. 
5 Ensure that policies informing health and care 
education and training equip professionals to 
work with people who use substances and need 
palliative or end of life care
1. Government 
departments and 
national associations 
governing professional 
education to include 
SU and PC/EoL care in 
their qualifying and post 
qualifying curricula.
2. National monitoring 
and quality inspections 
of residential and nursing 
care homes should 
incorporate assessment 
of staff education and 
training on end of life 
care and PSU.
3. Create and sustain 
a repository of 
information and 
resources to expand 
clinical awareness of 
PSU at EoL. 
1. Facilitate reciprocal 
training and shadowing 
of staff across services 
supporting people with 
PSU at end of life to 
increase knowledge 
and build professional 
relationships.
2. Support care homes 
to deliver end of life 
care (and minimise 
inappropriate sending of 
care home residents to 
die in hospital).
3. Maintain a database 
of good practice at local 
level and disseminate 
widely.
1. Training for SU and 
EoL care staff to have 
potentially difficult or 
sensitive conversations 
with people in their care 
and better deal with SU/
PC or EoL care needs.
2. Care homes to 
develop/refine policies 
and practice around 
working with people 
with substance 
problems.
3. Ensure staff have 
easy access to resources 
and information about 
supporting people with 
PSU, and their families, 
at EoL.
4. Specialist 
information and 
communication 
skills training around 
palliative care for SU 
staff and talking and 
asking about SU for  
EoL/PC staff.
4. National policy 
recognition that health 
and social care staff 
will require additional 
support and care when 
working with people with 
such complex needs.
4. Appoint people to 
key leadership roles that 
offer specialist inreach 
support and supervision 
across PC/EoL/SU and 
health and care sectors.
National Local Organisational
Training and education: examples
There	may	be	a	need	for	training	around	linking,	and	sharing	responsibility,	with	social	
and	health	care	services;	people	undertaking	neuro-triage	processes	may	require	greater	
understanding	of	the	individual’s	mental	and	physical	capacity.
Case studies: what good looks like
•  Many hospices accept people’s alcohol use without seeking to change it as they approach death, 
considering that the possible discomfort of abstaining from alcohol may only add to their distress. 
However, having attended a joint substance use/palliative care training day, one hospice palliative 
consultant asked a patient who was in the last few weeks of life if they would like to undergo an 
alcohol withdrawal regimen. They said yes and underwent a very successful detox. This experience 
was extremely beneficial for him and his family – allowing some meaningful conversations to 
take place before he died. From a medical point of view, it also made his symptom control more 
straightforward in the last two weeks of his life. The training had added another tool in the 
consultant’s toolkit of how to support people with problematic substance use at their end of life. 
Good palliative care policies relating to substance use thus need to tread the fine line between 
accepting that some people with substance problems will not wish to change their use, while others 
may welcome the opportunity and should be offered that chance. 
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It is well recognised that families, carers, friends play a central role in supporting people who are unwell 
(NHS, 2019). In the context of palliative and end of life care for people with problematic substance use 
(PSU), this caring role is vital. Key Standard 6 focusses on the people who are important to the person with 
PSU at the end of their lives.
6 Ensure policy identifies and responds to the needs 
of people who are important to the person with 
substance problems at the end of life
1. Develop specific PC/
EoLC policy on support 
for families of people 
with PSU – as carers, but 
also in terms of their own 
support needs.
2. National substance 
use and end of life 
care policies need to 
acknowledge the need 
for bereavement support 
for family members when 
someone dies with PSU 
because of the added 
shame and stigma it can 
bring.
1. Commission specialist 
support for families/ 
friends caring for relatives 
with PSU including those 
caring at EoL.
2. Ensure that family 
support service 
commissioning 
includes pre and post 
bereavement support.
3. Ensure young carers 
are acknowledged and 
their rights considered 
and addressed.*
1. Services to review/
expand existing policy to: 
(i) ensure professionals 
are clear on their role 
in supporting family 
members and carers, and 
(ii) ensure the provision 
of family peer support 
resources, e.g. groups, 
online forum.
2. Provide pre and post 
bereavement support to 
family members whose 
relative has died with/ 
through PSU – through 
direct support or through 
signposting to other 
services.
3. Develop policy guidance 
that: (i) supports staff 
to identify young carers 
and children in need of 
support, (ii) documents 
support needs and (iii) 
provides/signposts to 
appropriate services.
4. Ensure policy about 
family support includes 
guidance on working with 
family members where 
there are concerns about 
their behaviour or potential 
safeguarding concerns.
3. Acknowledge and 
embed the needs of 
young people and 
children caring for people 
at end of life with PSU 
into national policies on 
young carers, EoL and 
substance use policy.
*Guidance can be found at https://carers.org/know-your-rights-support-young-
carers-and-young-adult-carers-england
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In situations where the person dying has a 
substance problem, the need to support the 
family – both in terms of their caring role, but 
also with regard to their own support needs – is 
even more critical. It is imperative, therefore, that 
we develop policy and practice that recognises 
and delivers on support for family carers. The 
NHS Long Term Plan (NHS, 2019) has begun this 
conversation. However, appropriately resourced, 
specialist support needs to be available to families 
while giving care and after their family member 
has died. This support should include a focus 
on identifying and countering any increased 
vulnerabilities among children in these families 
(through Adverse Childhood Experiences – ACEs). 
Longer- term support may well be needed and 
good policy practice will factor this in to the 
commissioning process and in the organisational 
level support on offer. 
It is important for policies and practice to 
recognise that:
(1)  The term ‘family’ needs to be interpreted in 
the broadest sense – some people have no 
family or have become estranged from their 
families. Their closest relationship could be 
with friends or a worker.
(2)  There may be a need to reconnect people 
with their estranged families – to let the family 
know that their relative is approaching end of 
life; or find and support families when their 
relative has died. 
(3)  Ongoing bereavement support may be 
required for family, friends or carers – 
especially if they feel shame or guilt about 
what happened or consider that they have 
somehow failed their dead relative. 
(4)  People may not want their family told 
the details of their condition or care. It is 
important to note that there may need 
to be transparent yet gentle handling of 
situations where the family is asking for better 
communication from staff, but their relative 
has not given permission to break patient 
confidentiality.
(5)  The support needs of any children within 
the family should be of paramount concern, 
particularly if they have been a young carer 
and may feel quite traumatised by what has 
happened. Referrals for support to children’s 
social care may be needed or to a young 
carer’s service locally. Safeguarding referrals 
to social care should be made if there is any 
indication that children are being maltreated, 
their health or development is being or may 
be impaired, and if there are concerns about 
the child being safe and well cared for. Further 
information can be found in Working together 
to safeguard children (H. M. Government, 
2018).
(6)  Allocated key workers (i.e. substance use  
and/or homelessness key workers) or a 
person’s primary clinician may be the most 
important person in the life of someone with 
substance problems who has no one else to 
rely on. This may place a substantial emotional 
burden on those key workers, especially if a 
high proportion of their client group faces 
chronic health problems and premature 
death. They will need positive and effective 
supervision and support both in the workplace 
and easy access/referral to counselling and 
support outside of the workplace should they 
require it.
(7)  It is also important to acknowledge that not 
all family members, friends and carers will 
offer positive support to their family members, 
particularly if they have their own problematic 
substance use or complex needs. This can take 
up staff time and energy particularly where 
there are concerns about their involvement 
with their relative or safeguarding issues. Clear 
policies for staff are important to minimise the 
burden, acknowledge the challenges this can 
pose, and to support them to find a balance 
between supporting family members and 
protecting the person at end of life.
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Case studies: what good looks like
•  A hospice received a complaint from the man’s wife because, after five years of abstinence, he was 
offered, and accepted, alcohol from the hospice drinks trolley. He then bought more on his way home. 
The hospice was unaware of his history of problematic alcohol use. Unfortunately, he was abusive 
when drinking, and this return to drinking brought more stress to his wife. Good practice includes 
the systematic identification of people with (current or past) problematic alcohol or drug use in 
order to understand how best to support them. Routine enquiry about any current or past problems, 
allows medical treatment to be carefully attuned to the person’s healthcare needs, as well as avoid 
exacerbating family stress as in the example above. Policies need to recognise the time and resources 
necessary to properly attend to family dynamics and support everyone in caring for a relative with a 
substance problem. Without such support for families, informal care may be compromised, resulting 
in a greater reliance on medical services than would otherwise be necessary.
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Possible barrier to PC/EoL-SU policy 
implementation
Potential method of overcoming barrier
1.  Insufficient policy-level understanding of the 
depth/complexity of need among people with 
multiple complex needs. 
Need to build evidence base on people’s complex 
healthcare needs and how these are compounded for 
people with substance problems.
2.  [The above results in] Inappropriate levels 
of funding for only short-term/superficial 
interventions.
Current data collection/outcome measures need refining 
to enable them to evidence the quality of work required 
and the positive outcomes that can be attained through the 
funding of more intensive support.
3.  It is currently impossible to measure 
prevalence given lack of data. 
We need to be able to identify the scale of people with 
substance problems and PC/EoLC needs. NDTMS does not 
currently record complex health problems. Whilst data 
on cause of death for people in service (via Drug Related 
Death reports) could identify chronic health conditions and 
multiple morbidities, this will not inform us about PC/EoL 
care needs among existing service users. Nor will it identify 
the service users who drop out of services because their 
poor health precludes them from attending.
4.  Current Gold Standards Framework definition 
of/focus on end of life care is unhelpful for 
people with less predictable trajectories (i.e. 
organ failure) and so largely excludes people 
with substance problems.
The GSF needs to be expanded and refined to identify 
people with life shortening conditions which rapidly move 
between functioning (feeling well) to decompensating 
(acutely ill). Use of the Amber Care bundle will help 
facilitate this (see Practice Resources for a link).
5.  End of Life is generally defined by GPs, not 
all of whom are sympathetic to people with 
substance problems.
Need to recognise that everyone is in the early stages 
of learning about the interplay between palliative/
EoL care and substance use and accept that there is 
little/no clinical guidance as yet. Health and social care 
professionals need to be confident enough to share their 
uncertainties; explore each other’s thinking processes 
and priorities in order to reach common understanding; 
and develop practice themselves.
6.  Competition for contracts among different 
substance use providers inhibits sharing 
information about good practice.
Need to counter protectionism around services by 
commissioning partnership practice and rewarding 
innovative work.
There is little point in developing policy without the resources to implement those ideas on the ground. 
Asking people to get involved in policy work that has no scope to be applied to practice only risks them losing 
faith in the process and potentially declining involvement in future policy work. It is therefore imperative that 
policy development is accompanied by a commitment to: (1) adequately resource its implementation, and (2) 
evaluate and disseminate its impact. 
In addition to resource constraints, there are several other barriers to implementing policies in new fields of 
endeavour that warrant exploration here in order to ensure policy development starts with an awareness of 
barriers and contingency plans to overcome them.
Overcoming barriers to effective policy development and implementation
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There is an urgent need for policies that reiterate everybody’s right to equal access to health and social 
care. For palliative and end of life care, policies need to include giving people choices about how and 
where they spend the last months, weeks, and days of their lives.
The London End of Life Clinical Network defines a good death as:
… the best death that can be achieved in the context of the individual’s clinical diagnosis 
and symptoms, as well as the specific social, cultural and spiritual circumstances, taking into 
consideration patient and carer wishes and professional expertise. 
(London End of Life Clinical Network, undated)
What should happen next
There will always be some limitations to the 
choices that people can be offered due to 
resource limitations and availability at the time 
needed. But it is apparent that access to existing 
palliative and end of life care is particularly limited 
for people with problematic substance use. Choice 
is usually not an option for them. Where people 
are being cared for in the community, it is families, 
friends and other people important to them, 
who provide the care. These people comprise 
a currently unrecognised and underserved 
population who often need support and care in 
their own right.
These policy standards begin the conversation 
about improving support for people with 
problematic substance use at, or near, the end of 
their lives. They are not intended to be the final 
word. They are intended to instigate policy activity 
at each of the three levels outlined: national, 
local and organisational. They should be used by 
organisations in a flexible way, with new activities 
being added and older ones replaced as the wider 
policy and practice environment dictates and as 
we learn more about people’s experiences of 
living, and dying, with problematic substance use.
Partnership in policy and practice
Good policy practice is achievable as the case 
studies in this document testify. In these early 
days of policy development, this is an area of 
mutual learning that is ripe for innovative and 
timely integrated working. Many of the examples 
given are practice based, and we hope that 
national and local policy will capitalise on this 
frontline knowledge, as well as working to inspire 
and direct it. As always, the success of innovative 
policy and practice requires strong leadership at 
all levels, combined with a willingness to learn 
from colleagues and people with lived experience. 
If you fund, commission or provide palliative 
care, end of life care or substance use services, 
we ask that you consider how to identify and 
respond to this group of people who, as evidence 
of our ageing demographic suggests, will continue 
to grow. Better recording and monitoring of 
people will help to shore up the limited evidence 
base and assist in planning future services and 
care. Moreover, greater engagement with people 
in existing services, and with the people important 
to them, can only serve to improve our knowledge 
and understanding. 
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If you provide primary or acute health care, we 
ask that you seek to promote good practice and 
help colleagues to avoid making stereotypical 
judgements about the reasons for people with 
PSU, past or present, presenting for health care. 
People with problematic substance use usually 
have a range of difficult and traumatic histories 
and respond well to warmth and empathy. 
Avoid assuming that their health complaints are 
only a way to acquire medication, or that basic 
instructions to “stop using” substances will resolve 
their ill health. Where appropriate, speak openly 
and sensitively to people about advance care 
planning and their wishes at the end of life.
If you provide substance use, palliative care or 
social care services, commit to learning more and 
to working together both to improve your practice 
with the people you support and also to access 
support and advice in your own right. People living, 
and dying, with problematic substance use may 
have complex, multiple needs and there is no need 
to respond to that on your own. Continue to seek 
out support, build relationships and champion good 
interagency and inter-disciplinary working.
As a person in your own community we ask that 
you help your families, friends and neighbours 
to understand more clearly the needs and 
inequalities faced by this group of people as 
they approach the end of their lives. This may be 
by offering individual support, supporting local 
services, or by challenging stereotypes and stigma 
when you hear them. Reaching out to family 
members, friends and carers can also offer a much 
needed lifeline for people living with stigmatised 
grief and loss. No one begins life with the 
intention of developing a problem with alcohol or 
other drugs and, at the end of their lives, people 
deserve to die with dignity and respect. 
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Appendix A – Resources
Policy links
Alcohol and Other Drugs
End of life care for people with problematic substance use
Research Briefings, Full Reports, Good Practice Guidance, and other resources from 
Manchester Metropolitan University’s research on end of life care for people with problematic 
substance use. Available at: https://endoflifecaresubstanceuse.com/  
To be added to the Community of Practice network at ManMet, please contact Dr Sam Wright 
on sam.wright@mmu.ac.uk 
alcoholpolicy.net
Very useful resource with weekly updates on 
alcohol policy. The link below gives a brief 
summary of alcohol policy history. At the time of 
writing, there is a new alcohol strategy planned 
but no clarity about when it will be published.
https://www.alcoholpolicy.net/2018/05/new-
alcohol-strategy-plans-and-further-minimum-
pricing-review.html
Alcohol and drug treatment and recovery  
– why invest?
https://www.gov.uk/government/publications/
alcohol-and-drug-prevention-treatment-and-
recovery-why-invest/alcohol-and-drug-prevention-
treatment-and-recovery-why-invest
Alcohol Commissioning Support 2019-2020: 
principles and indicators
https://www.gov.uk/government/publications/
alcohol-drugs-and-tobacco-commissioning-
support-pack/alcohol-commissioning-suport-pack-
2018-to-2019-principles-and-indicators
Drug Strategy 2017
https://www.gov.uk/government/publications/
drug-strategy-2017
Drug Misuse Treatment in England: Evidence  
of Outcomes
https://www.gov.uk/government/publications/
drug-misuse-treatment-in-england-evidence-
review-of-outcomes
EU alcohol strategy
https://www.parliament.uk/business/committees/
committees-a-z/lords-select/eu-home-affairs-
sub-committee-f-/news/alcohol-strategy-report-
publication/
Local Alcohol Profiles for England
https://www.slideshare.net/PublicHealthEngland/
local-alcohol-profiles-for-england-february-2019
NICE guidance on alcohol
https://www.nice.org.uk/guidance/lifestyle-and-
wellbeing/alcohol
NICE guidance on drug misuse
https://www.nice.org.uk/guidance/health-
protection/drug-misuse
Statistics on Alcohol, England 2019 
https://digital.nhs.uk/data-and-information/
publications/statistical/statistics-on-alcohol/2019
United Kingdom Drug Report 2018
http://www.emcdda.europa.eu/countries/drug-
reports/2018/united-kingdom_en
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Palliative and End of Life Care
Ambitions for Palliative and End of Life Care
http://endoflifecareambitions.org.uk/
Deaths related to drug poisoning in England  
and Wales. Statistical Bulletins.
https://www.ons.gov.uk/
peoplepopulationandcommunity/
birthsdeathsandmarriages/deaths/bulletins/
deathsrelatedtodrugpoisoninginenglandandwales/
previousReleases
Dying to care: a report into social care at  
the end of life
https://www.mariecurie.org.uk/globalassets/
media/documents/policy/policy-publications/
december-2016/dying_to_care.pdf
Equity in the provision of palliative and end of 
life care in the UK
https://www.mariecurie.org.uk/globalassets/
media/documents/policy/marie-curie-reports/
state-of-the-nations-mariecurie-report-england.pdf
Gold Standards Framework
http://www.goldstandardsframework.org.uk/
Hospice UK policy priorities
https://www.hospiceuk.org/policy-advocacy/
policy-priorities
Making Every Adult Matter (MEAM)
http://meam.org.uk/multiple-needs-and-
exclusions/
Marie Curie’s Policy publications archive
https://www.mariecurie.org.uk/policy/publications
NICE End of Life Care documents
https://www.nice.org.uk/guidance/health-and-
social-care-delivery/end-of-life-care
Pallaborative Network
A collaboration of health care professionals 
working in specialist palliative care, patients and 
members of the public from across the North 
West of England, working to improve the quality 
of care for people with advanced progressive 
disease and to ensure care is based on the best 
and most up to date evidence possible. The 
website contains a range of clinical audit, guideline 
development and education materials, useful for 
all health care professionals who care for people 
with advanced, progressive disease. The clinical 
standards and guidelines for palliative and end of 
life care are developed using a robust process and 
are NICE accredited. https://pallaborative.org.uk/
Palliative Care and the UK nations, implications 
for England
https://www.mariecurie.org.uk/globalassets/
media/documents/policy/marie-curie-reports/
state-of-the-nations-mariecurie-report-england.pdf
The GSF Prognostic Indicator Guidance 
https://www.goldstandardsframework.org.uk/
cd-content/uploads/files/General%20Files/
Prognostic%20Indicator%20Guidance%20
October%202011.pdf
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Practice resources
Adfam 
Adfam is the national organisation working with 
and for families affected by drugs and alcohol. 
https://www.adfam.org.uk  
Al-Anon Family Groups 
This fellowship, based on 12 step models of peer 
support, offer support to families affected by  
a relative’s problem drinking.  
http://www.al-anonuk.org.uk/
Amber Care Bundle 
A communication and planning tool for clinical 
teams to proactively manage the care of hospital 
patients who are facing an uncertain recovery and 
who are at risk of dying despite treatment.  
https://www.ambercarebundle.org/homepage.
aspx [Accessed 26th March 2019] See also:  
Guy’s and St Thomas’ NHS Foundation Trust 2015 
The AMBER care bundle – a guide for patients, 
their relatives and carers.  
https://www.ambercarebundle.org/documents/
amber-care-bundle-a-guide-for-patients-their-
relatives-and-carer.pdf  
[Accessed 26th March 2019]
Cruse 
Cruse supports people who have been bereaved 
due to the death of someone close.  
http://www.cruse.org.uk/
DrugFAM 
DrugFAM provides support to families, friends and 
carers who are struggling to cope with a loved 
one’s addiction to drugs or alcohol.  
http://www.drugfam.co.uk/  
Dying Matters
Dying Matters aims to help people talk more 
openly about dying, death and bereavement, and 
to make plans for the end of life. Among a range 
of services, it offers Find Me Help which is the 
UK’s most comprehensive directory of services for 
people in the last years of life, their families, carers 
and friends – https://www.dyingmatters.org/ 
[Accessed 26th March 2019]
IRISS
Evidence summary on palliative and end of life 
care for people with alcohol-related brain damage. 
https://www.iriss.org.uk/resources/esss-outlines/
palliative-care-arbd
Macmillan Cancer Support 
Macmillan provides practical, medical and 
financial support and end of life care and pushes 
for better cancer care.  
http://www.macmillan.org.uk/information-and-
support/coping/at-the-end-of-life
National Council for Palliative Care
NCPC is an umbrella charity for organisations in 
the UK working with people in palliative or end  
of life care. https://www.ncpc.org.uk/  
[Accessed 26th March 2019]
The Royal College of Anaesthetists (RCoA)
The UK professional body responsible for the 
quality of patient care through the maintenance 
of standards in anaesthesia, critical care and pain 
medicine – provides a lot of useful information 
about opioid use and pain management:  
https://www.rcoa.ac.uk/faculty-of-pain-medicine/
opioids-aware/opioids-and-addiction/palliative-
care
Rowcroft Hospice
Guidance on prescribing for people with using 
substances.  
https://www.rowcrofthospice.org.uk/wp-content/
uploads/Rowcroft-Hospice-Palliative-Care-
Prescribing-For-Substance-Misusers.pdf
The Serious Illness Conversation Guide
https://www.ariadnelabs.org/wp-content/
uploads/sites/2/2015/08/Serious-Illness-
Conversation-Guide-5.22.15.pdf
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The Society for the Study of Addiction (SSA)
https://www.addiction-ssa.org/factsheets  
The SSA has a range of factsheets available split 
into categories. The first category includes a 
factsheet on Palliative Care, the third category 
includes a factsheet on communication and 
substance use. However, there are range of 
factsheets that will likely be of interest.
SMART Recovery Family and Friends Programme 
SMART UK offers group-based support to those 
affected by another’s substance use. 
https://www.smartrecovery.org.uk/family-friends/
The Supportive and Palliative Indicators Care 
Tool (SPICT).
Devised by the University of Edinburgh (Updated) 
(2018) www.spict.org.uk  
[Accessed 26th March 2019]

